FDA approves new trial design for ALS therapy NurOwn
NeurologyLive - 10-Apr-2024Specialized protocol aims to address early-stage ALS and advance regulatory approval efforts
Join the club for FREE to access the whole archive and other member benefits.
Editor for NeurologyLive
Marco Meglio is an accomplished editor with NeurologyLive, a part of MJH Life Sciences®, where he has demonstrated expertise in content creation and editorial leadership over more than five years. Since becoming Editor in January 2023, Marco has expanded his contributions by producing high-quality written and video content, with over 500 pieces published in 2022 alone. His role involves preparing daily newsletters, editing articles, attending scientific conferences, and conducting on-site clinician interviews to enhance the brand's presence in the neurology field. He also launched a series highlighting unique institutions and care models within the neurology community. Previously serving as Associate Editor, Marco's dedication to refining his craft and covering impactful topics in neurology has made him a valuable voice in medical journalism.
Visit website: https://www.neurologylive.com/authors/marco-meglio
See also: NeurologyLive - News source for breaking drug approvals, pipeline trials and emerging trends in neurology.
Details last updated 20-Nov-2024
Specialized protocol aims to address early-stage ALS and advance regulatory approval efforts